Vedolizumab Plus Post-transplant Cyclophosphamide and Short Course Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Reduced Intensity Conditioning
Abroad (travel likely)RecruitingPHASE2
Conditions
Acute Lymphoblastic Leukemia · Acute Myeloid Leukemia · Chronic Myelomonocytic Leukemia · Graft Versus Host Disease · Myelodysplastic Syndrome · Myeloproliferative Neoplasm
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
City of Hope Medical Center, Duarte, California, United States
Contact: Principal Investigator (Monzr M. Al Malki)
Study leads
Monzr M. Al Malki
Principal Investigator
City of Hope Medical Center